Cost-Effectiveness Analysis of Long-acting Injectable Once-monthly of Aripiprazole Compared with Long-acting Injectable Once-monthly Paliperidone Palmitate for the Treatment of Stable Schizophrenia Patients in Thailand

Objective: Long-acting injectable (LAI)-aripiprazole and LAI-paliperidone palmitate are both second-generation antipsychotics that have been introduced to increase drug compliance in patients. These attributes are expected to enhance drug compliance, particularly in stable patients. The previous st...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Piyanut Ueapanjasin, Wiwat Thavornwattanayong, Jadesada Lertsirimunkong, Kamolpat Chaiyakittisopon
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Faculty of Medicine Siriraj Hospital 2023-10-01
Edice:	Siriraj Medical Journal
Témata:	Aripiprazole cost-effectiveness long-acting injectable antipsychotics paliperidone stable schizophrenia patients
On-line přístup:	https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/264770
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!